A review evaluated the distribution and predictive capabilities of three genomic assays for breast cancer across different ...

Genomic testing, while sometimes a difficult subject to navigate with patients, is an essential part of oncology in which nurses and advanced practice providers (APPs) should be well-versed, according ...

Cambridge researchers developed PRRDetect, an algorithm identifying tumors with DNA repair faults, enhancing personalized ...

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal ...

The PRRDetect algorithm identifies hidden DNA repair flaws in tumors It helps doctors choose effective therapies based on the ...

A new study shows that Arima Genomics’ technology detects actionable cancer drivers in solid tumors missed by FISH, RNA, and DNA sequencing tests.

Elevated circulating tumor DNA (ctDNA) fraction and tumor suppressor gene loss are associated with worse prognosis in patients with prostate cancer liver metastases (PCLM), according to investigators.

Fasting has shown its potential to reduce colorectal cancer risk by triggering cellular changes that may slow tumor growth, ...

Results of a study show convergent genetic adaptation under hypoxia (lack of oxygen) between populations living at ...

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human ...

In his talk, Dr. Perou will share his journey from research to entrepreneurship, highlighting the challenges and lessons learned in transforming his cancer genomics research into a successful startup ...